207_Combined course Presentations
KROG 07-01
• Phase II study
• 79 = CA9-positive, 37 = CA9-negative
• Randomised to pelvic vs. extended field RT + chemo
Kim JH, et al. Radiother Oncol. 2016;120(3):383-9
Made with FlippingBook
KROG 07-01
• Phase II study
• 79 = CA9-positive, 37 = CA9-negative
• Randomised to pelvic vs. extended field RT + chemo
Kim JH, et al. Radiother Oncol. 2016;120(3):383-9
Made with FlippingBook